Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression
about
Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytesVirion assembly factories in the nucleus of polyomavirus-infected cellsTetraspanin CD151 mediates papillomavirus type 16 endocytosisInteraction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infection.Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infectionA membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes.RNA-templated replication of hepatitis delta virus: genomic and antigenomic RNAs associate with different nuclear bodiesCurrent understanding of the mechanism of HPV infectionThe l2 minor capsid protein of low-risk human papillomavirus type 11 interacts with host nuclear import receptors and viral DNAThe cytoskeleton in papillomavirus infectionConcepts of papillomavirus entry into host cellsAn Adenovirus DNA Replication Factor, but Not Incoming Genome Complexes, Targets PML Nuclear Bodies.Large scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomavirusesEntry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosisMolecular mechanisms of HPV mediated neoplastic progressionThe Role of Nuclear Antiviral Factors against Invading DNA Viruses: The Immediate Fate of Incoming Viral GenomesThe Role of the DNA Damage Response throughout the Papillomavirus Life CycleEstablishment of human papillomavirus infection requires cell cycle progressionTarget cell cyclophilins facilitate human papillomavirus type 16 infectionDifferentiation-dependent interpentameric disulfide bond stabilizes native human papillomavirus type 16Direct binding of retromer to human papillomavirus type 16 minor capsid protein L2 mediates endosome exit during viral infectionBovine papillomavirus type 1 infection is mediated by SNARE syntaxin 18Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppression.A central region in the minor capsid protein of papillomaviruses facilitates viral genome tethering and membrane penetration for mitotic nuclear entry.Translocation of the papillomavirus L2/vDNA complex across the limiting membrane requires the onset of mitosisEfficient Production of Papillomavirus Gene Delivery Vectors in Defined In Vitro Reactions.Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus.The association of viral proteins with host cell dynein components during virus infection.The nuclear retention signal of HPV16 L2 protein is essential for incoming viral genome to transverse the trans-Golgi network.Human papillomavirus type 16 E1circumflexE4 contributes to multiple facets of the papillomavirus life cycle.In vivo mechanisms of vaccine-induced protection against HPV infection.Papillomavirus infection requires gamma secretase.Vesicular trafficking of incoming human papillomavirus 16 to the Golgi apparatus and endoplasmic reticulum requires γ-secretase activity.Human alpha-defensins block papillomavirus infectionImprovement of different vaccine delivery systems for cancer therapy.Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection.Differential expression of HPV16 L2 gene in cervical cancers harboring episomal HPV16 genomes: influence of synonymous and non-coding region variationsHuman papillomavirus species-specific interaction with the basement membrane-resident non-heparan sulfate receptor.Alpha-defensin HD5 inhibits furin cleavage of human papillomavirus 16 L2 to block infection.Replication and partitioning of papillomavirus genomes.
P2860
Q21143868-8D0CF5B1-F36B-4357-9151-48EF1083AD1CQ21558475-DA2D126C-BC91-4D3B-9797-8BD596336FBCQ24307905-174D1E33-BB11-4514-8BB9-9F0942D225D0Q24524176-CCF219E2-56BA-4C8A-A7F1-FF135FCBD873Q24537437-6D35EADC-486F-45D6-A07E-1EEF3BE5BDF5Q24537580-AD32EBC6-0854-4231-9F3D-B6531B2B9249Q24548934-79590002-838B-4CDE-89FA-9255E1BC7502Q24616134-AEF298A7-6FD1-45C8-9DCB-51C8F753A83EQ24674159-E9791245-CBC5-449E-863B-0DE439AF0ED4Q26861667-3E5AF6D4-4B3A-487F-896F-D8975D8A4C28Q27026900-A6D22AD8-029F-4E3E-A81A-3BBEE11E3F0CQ27320996-848B3C28-0E91-4BEE-83AD-E0830659C5D8Q27325402-336857F7-F5FC-4B9F-A0B3-C1A6081481A7Q27346336-C26657DA-1D29-4A37-8B63-A6A31A514A07Q28070323-BCE8C848-B4C6-48AA-891D-66C59138FE76Q28071373-BBAB7E3C-DFDE-45A3-9012-FDFDF4CA5AABQ28081948-63D3E7C8-A885-4269-BC1F-12657CA6D915Q28474811-05B21380-8AF8-487D-AFFC-D2EDFA09CB08Q28475787-CD11F116-FD86-4073-8484-9221A4D76354Q28479209-3AB8D360-99E8-4F36-A2A1-E3EF457759F5Q28543528-99C414FC-B335-45AB-A8DB-5C557CE6C6F5Q28593400-EAE5AA55-840A-47EE-820E-6A5EE4297B9EQ33604135-2CBC1D67-98D0-457F-97A3-CBAE1674150FQ33626382-9C579ECC-8A20-4048-A61B-E9D15E0D30F5Q33626389-0758AD7C-1BD9-4123-8548-541BA0A508B1Q33652425-824887B5-8FCE-43C4-AF26-49CC676E0A5EQ33815559-CA9B36AA-A174-475C-8FA8-F400F4063968Q33967271-72835CA2-1195-4118-939B-525DDE813FF9Q33970900-2F644E6B-21A5-4AAF-A914-3598661FBC4CQ34045582-976D953D-6CAD-4994-938B-0AF5B59716B5Q34125906-09A0C556-D340-4F48-B389-467BAB5810FEQ34178325-D464EDAB-F807-41BF-B5BB-D8BD3593264BQ34229884-51A87960-64FD-4ACC-9A6E-643C6A70BF52Q34334899-4D0B5BBE-FED2-4C62-AC4F-2419B8A55FCDQ34506877-6EC1B353-7D89-4337-95C5-3D5B6E3C32B2Q34576051-46A50765-579F-4400-963B-5D68494FCC85Q34770066-2DB7D986-9F84-4987-AA4F-985AA807B1FDQ34774775-52EA6DD1-784E-4B1A-B2B8-795D4755123AQ35076730-D7646EDA-CF64-4FFF-BAD4-DCFF75606D58Q35150925-972F3F95-8C45-4238-9DAB-B4BA99F4243D
P2860
Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Establishment of papillomaviru ...... kemia protein (PML) expression
@ast
Establishment of papillomaviru ...... kemia protein (PML) expression
@en
Establishment of papillomaviru ...... kemia protein (PML) expression
@nl
type
label
Establishment of papillomaviru ...... kemia protein (PML) expression
@ast
Establishment of papillomaviru ...... kemia protein (PML) expression
@en
Establishment of papillomaviru ...... kemia protein (PML) expression
@nl
prefLabel
Establishment of papillomaviru ...... kemia protein (PML) expression
@ast
Establishment of papillomaviru ...... kemia protein (PML) expression
@en
Establishment of papillomaviru ...... kemia protein (PML) expression
@nl
P2093
P2860
P3181
P356
P1476
Establishment of papillomaviru ...... kemia protein (PML) expression
@en
P2093
Carl C Baker
Douglas R Lowy
John T Schiller
Patricia M Day
P2860
P304
P3181
P356
10.1073/PNAS.0404229101
P407
P577
2004-09-28T00:00:00Z